Home / Feed item / Samantha Yammine: $225M Versant & Bayer funding to Blue Rock the 2nd largest series A funding in the world. Toronto's #stemcell #biotech scene is !
Samantha Yammine: $225M Versant & Bayer funding to Blue Rock the 2nd largest series A funding in the world. Toronto's #stemcell #biotech scene is !
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
